Article Text

other Versions

Download PDFPDF
Audit, research and guideline update
NICE guideline: management of venous thromboembolic diseases and role of thrombophilia testing
  1. Luke S Howard1,
  2. Rodney J Hughes2
  1. 1National Pulmonary Hypertension Service, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK
  2. 2Department of Respiratory Medicine, Northern General Hospital, Sheffield, UK
  1. Correspondence to Dr Luke S Howard, National Pulmonary Hypertension Service, Hammersmith Hospital, Imperial College Healthcare NHS Trust, Du Cane Road, London W12 0HS, UK; l.howard{at}imperial.ac.uk

Abstract

The National Institute for Health and Clinical Excellence recently published a clinical guideline on the management of venous thromboembolic disease and thrombophilia testing. Several stand-out recommendations are made which may be practice changing for many physicians, such as catheter-directed thrombolysis for ilio-femoral deep venous thrombosis, routine cancer screening and extended duration of anticoagulation for unprovoked events. In this article, we summarise the key points of the guideline and discuss remaining areas of controversy.

  • Pulmonary Embolism

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.